Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Inv. presentation
|
|
ARS Pharmaceuticals, Inc. (SBTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/09/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/01/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/10/2022 |
3
| Shah Pratik (10% Owner) has filed a Form 3 on ARS Pharmaceuticals, Inc. |
| 11/10/2022 |
3
| Karas Eric (Chief Commercial Officer) has filed a Form 3 on ARS Pharmaceuticals, Inc. |
| 11/10/2022 |
3
| Lowenthal Richard E (President and CEO) has filed a Form 3 on ARS Pharmaceuticals, Inc. |
| 11/10/2022 |
3
| Kelly Michael (Director) has filed a Form 3 on ARS Pharmaceuticals, Inc. |
| 11/10/2022 |
3
| Scott Kathleen D. (CFO) has filed a Form 3 on ARS Pharmaceuticals, Inc. |
| 11/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/10/2022 |
3
| Chakma Justin (Chief Business Officer) has filed a Form 3 on ARS Pharmaceuticals, Inc. |
| 11/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/08/2022 |
3
| Pepe Jeffrey C. (Interim CEO and GC) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 03/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/03/2020 |
3
| CAPPS VICKIE L (Director) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| Alexandria Venture Investments, LLC (10% Owner) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| Odegard Valerie (President and CSO) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| Schroeder Thilo (Director) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| Islam Saqib (Director) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| Hawkinson Russ (Sr. Vice President of Finance) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| Presidio Management Group XII, L.L.C. (10% Owner) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| HERSHBERG ROBERT (Director) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| Thompson Peter A. (10% Owner) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| Hunder Naomi (Chief Medical Officer) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| Shawver Laura (CEO) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| Piazza Jonathan (CFO) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| ROOT JONATHAN D (10% Owner) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 12/03/2020 |
3
| Powell Andrew Kenneth William (Director) has filed a Form 3 on Silverback Therapeutics, Inc. |
|
|